| Also known as |
Lercanidipine hydrochloride |
| Blood pressure |
Reduces systolic and diastolic blood pressure |
| Chemical name |
2-[(3,3-Diphenylpropyl)(methyl)amino]-1,1-dimethylpropyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| Dosage (medical) |
10 mg or 20 mg once daily |
| Dosage (sports) |
Not applicable |
| Effects |
Lowering blood pressure, reducing strain on the heart |
| Formula |
C36H41N3O6 |
| Half-life |
8-10 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not specific |
| Main action |
Vasodilator |
| Raw Material |
Lacidipine |
| Side effects |
Dizziness, headache, flushing, edema, fatigue, palpitations, gastrointestinal disturbances |
| Storage conditions |
Store at room temperature, away from light and moisture |
| Substance class |
Calcium channel blocker |
| Trade name |
Zanidip, Carmen |
| Use in sports |
Not typically used |
| Water Retention |
Possible, as peripheral edema |
| Manufacturer |
GlaxoSmithKLline |
| Packing |
1 x 28 tabs (4 mg/tab) |
